Invivodata inc., the industry leader in patient reported outcomes (PRO) solutions
for clinical research, today announced the first integration of data from ACCU-CHEK(R)
blood glucose meters from Roche Diagnostics with the DiaryPRO(TM) handheld patient
diary from invivodata during a clinical trial. This advance was achieved using
SyncPRO(TM), invivodata's integration module for improving the accuracy of all
patient-reported measures in clinical trials.
Genetic Engineering News